...
首页> 外文期刊>BMC Structural Biology >Crystal structure of Leishmania tarentolae hypoxanthine-guanine phosphoribosyltransferase
【24h】

Crystal structure of Leishmania tarentolae hypoxanthine-guanine phosphoribosyltransferase

机译:塔氏利什曼原虫次黄嘌呤-鸟嘌呤磷酸核糖基转移酶的晶体结构

获取原文
           

摘要

Background Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (EC 2.4.2.8) is a central enzyme in the purine recycling pathway. Parasitic protozoa of the order Kinetoplastida cannot synthesize purines de novo and use the salvage pathway to synthesize purine bases, making this an attractive target for antiparasitic drug design. Results The glycosomal HGPRT from Leishmania tarentolae in a catalytically active form purified and co-crystallized with a guanosine monophosphate (GMP) in the active site. The dimeric structure of HGPRT has been solved by molecular replacement and refined against data extending to 2.1 ? resolution. The structure reveals the contacts of the active site residues with GMP. Conclusion Comparative analysis of the active sites of Leishmania and human HGPRT revealed subtle differences in the position of the ligand and its interaction with the active site residues, which could be responsible for the different reactivities of the enzymes to allopurinol reported in the literature. The solution and analysis of the structure of Leishmania HGPRT may contribute to further investigations leading to a full understanding of this important enzyme family in protozoan parasites.
机译:背景次黄嘌呤-鸟嘌呤磷酸核糖基转移酶(HGPRT)(EC 2.4.2.8)是嘌呤回收途径中的核心酶。 Kinetoplastida的寄生原生动物不能从头合成嘌呤,而不能使用挽救途径来合成嘌呤碱基,这使其成为抗寄生虫药物设计的有吸引力的目标。结果来自塔氏Leishmania tarentolae的糖体HGPRT以催化活性形式被纯化,并与鸟嘌呤单磷酸鸟苷(GMP)共结晶。 HGPRT的二聚体结构已通过分子置换解决,并针对扩展至2.1的数据进行了改进。解析度。该结构揭示了活性位点残基与GMP的接触。结论对利什曼原虫和人类HGPRT活性位点的比较分析显示,配体位置及其与活性位点残基的相互作用存在细微差异,这可能是文献报道的酶对别嘌呤醇的不同反应性的原因。利什曼原虫HGPRT结构的解决方案和分析可能有助于进一步研究,从而使人们对原生动物寄生虫中这一重要酶家族有充分的了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号